Atrial and Vascular Oxidative Stress in Patients with Heart Failure

被引:15
|
作者
Rochette, Luc [1 ]
Tatou, Etienne [2 ]
Maupoil, Veronique [1 ]
Zeller, Marianne [1 ]
Cottin, Yves [1 ,2 ]
Jazayeri, Sahed [2 ]
Brenot, Roger [2 ]
Girard, Claude [1 ,2 ]
David, Michel [2 ]
Vergely, Catherine [1 ]
机构
[1] Fac Med & Pharm Dijon, IFR Sante STIC, LPPCE, F-21079 Dijon, France
[2] CHU, Dijon, France
关键词
Norepinephrine; Lipid peroxidation; Iron; Heart failure; Patients; ACUTE MYOCARDIAL-INFARCTION; STAGE FAILING HEART; DILATED CARDIOMYOPATHY; REGIONAL HETEROGENEITY; AUTONOMIC INNERVATION; IRON; NOREPINEPHRINE; FIBRILLATION; HYPERTROPHY; RAT;
D O I
10.1159/000329951
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heart failure is characterized by a great number of metabolic and histological defects, however, previous studies did not provide strong evidence of a correlation between the antioxidant status of myocardial tissue itself and cardiac function. The goal of our study was to assess, in patients with heart failure consecutive to dilated cardiomyopathy (DCM), alterations in norepinephrine (NE), lipid peroxidation (malonedialdehyde: MDA) and iron levels in different parts of the myocardium and aorta, in relation to functional parameters. Biopsied heart samples were obtained from 12 DCM patients and from 4 brain-dead organ donors (Controls). The left ventricular ejection fraction (LVEF) was reduced to 19.1 +/- 2.6% in DCM. For all patients, the distribution of NE in the atria, ventricles and vessels was different, but NE content in control hearts was systematically higher than in cardiomyopathy patients. MDA levels tended to be higher in the different samples from the DCM group in comparison with the values obtained in the C group; the values were significantly decreased (p < 0.05) in endocardium and the aortic samples. In the right atrium there was a significant correlation between NE content and LVEF and between MDA and iron concentrations. These findings could give further insights into the relationship between iron metabolism disturbances and the severity of cardiovascular diseases. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:497 / 502
页数:6
相关论文
共 50 条
  • [21] Biomarkers of oxidative stress and heart failure
    Kamceva, G.
    Vavlukis, M.
    Kitanoski, D.
    Zdravkovska, M.
    Dokuzova, S.
    Kedev, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 399 - 399
  • [22] Oxidative stress in congestive heart failure
    Singal P.K.
    Khaper N.
    Farahmand F.
    Belló-Klein A.
    Current Cardiology Reports, 2000, 2 (3) : 206 - 211
  • [23] Mitochondrial oxidative stress and heart failure
    Tsutsui, Hiroyuki
    INTERNAL MEDICINE, 2006, 45 (13) : 809 - 813
  • [24] The role of oxidative stress in heart failure
    Gal Roland
    Halmosi Robert
    ORVOSI HETILAP, 2015, 156 (47) : 1916 - 1920
  • [25] Thioredoxin:: A new marker of oxidative stress in patients with chronic heart failure
    Jekell, A
    Hossain, A
    Rosén, A
    Dahlström, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 176A - 176A
  • [26] Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure
    Tanaka, Toshinari
    Tsutamoto, Takayoshi
    Nishiyama, Keizo
    Sakai, Hiroshi
    Fujii, Masanori
    Yamamoto, Takashi
    Horie, Minoru
    CIRCULATION JOURNAL, 2008, 72 (04) : 563 - 568
  • [27] Effect of Waon Therapy on Oxidative Stress in Patients With Chronic Heart Failure
    Fujita, Shoji
    Miyata, Masaaki
    Kihara, Takashi
    Fukudome, Tsuyoshi
    Shinsato, Takuro
    Kubozono, Takuro
    Kuwahata, So
    Yamaguchi, Tsuyoshi
    Hamasaki, Shuichi
    Torii, Hiroyuki
    Tei, Chuwa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A187 - A187
  • [28] Predictors of oxidative stress in heart failure patients with Cheyne–Stokes respiration
    Ana C. Krieger
    Daniel Green
    Muriel T. Cruz
    Frank Modersitzki
    Gita Yitta
    Sanja Jelic
    Doris S. Tse
    Steven P. Sedlis
    Sleep and Breathing, 2011, 15 : 827 - 835
  • [29] Oxidative stress and hemodynamic parameters in heart failure patients with dilated cardiomyopathy
    Jachec, W.
    Wojciechowska, C.
    Skrzep-Poloczek, B.
    Romuk, E.
    Kozielska, E.
    Birkner, E.
    Wodniecki, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 1 - 2
  • [30] Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine oxidase and extracellular superoxide dismutase
    Landmesser, U
    Spiekermann, S
    Dikalov, S
    Wilke, R
    Tatge, H
    Hornig, B
    Drexler, H
    CIRCULATION, 2002, 106 (19) : 571 - 571